JOINT VENTURE, TECHNOLOGY LICENSE AND OTHER AGREEMENTS WITH MICRON TECHNOLOGY, INC (Details) (USD $)	12 Months Ended			3 Months Ended	12 Months Ended					12 Months Ended
	Nov. 03, 2013	Oct. 28, 2012	Oct. 30, 2011	Apr. 29, 2012 Capital Lease Obligations With Micron [Member]	Nov. 03, 2013 Equity Method Investee [Member]	Oct. 28, 2012 Equity Method Investee [Member]	Oct. 30, 2011 Equity Method Investee [Member]	Nov. 03, 2013 Co-venturer [Member]	Oct. 28, 2012 Co-venturer [Member]	Nov. 03, 2013 Supply Agreement [Member]	Oct. 28, 2012 Supply Agreement [Member]	Oct. 30, 2011 Supply Agreement [Member]
Related Party Transaction [Line Items]
Variable Interest Entity, Methodology for Determining Whether Entity is Primary Beneficiary	This joint venture is a variable interest entity ("VIE") (as that term is defined in the Accounting Standards Codification ("ASC") ) because all costs of the joint venture are passed on to the Company and Micron through purchase agreements they have entered into with the joint venture, and it is dependent upon the Company and Micron for any additional cash requirements. On a quarterly basis the Company reassesses whether its interest in MP Mask gives it a controlling financial interest in this VIE. The purpose of this quarterly reassessment is to identify the primary beneficiary (which is defined in the ASC as the entity that consolidates a VIE) of the VIE. As a result of the reassessments in fiscal year 2013, the Company determined that Micron is still the primary beneficiary of the VIE, by virtue of its tie-breaking voting rights within MP Mask's Board of Managers, thereby giving it the power to direct the activities of MP Mask that most significantly impact its economic performance, including its decision making authority in the ordinary course of business and its purchasing the majority of products produced by the VIE.
Additional investment in joint venture	$ 0	$ 13,400,000
Distributions from Joint Venture	0	0
Maximum exposure to loss from investment in VIE	93,100,000	93,300,000
Income (Loss) from equity-method investee	(100,000)	(100,000)	600,000
Amount owed to MP Mask	4,500,000	6,400,000
Amount receivable from Micron Technology, Inc.	73,357,000	75,685,000						4,900,000	9,000,000
Commission revenue earned under supply agreement	900,000	1,600,000	1,700,000
Amortization of Supply Agreement	5,500,000	5,000,000	5,300,000							300,000	400,000	500,000
Cost of sales	322,540,000	338,519,000	375,806,000		8,700,000	7,600,000	18,500,000
Research and development expenses and other	20,758,000	19,371,000	15,507,000		1,600,000	2,000,000	3,100,000
Purchase of Equipment	6,100,000	1,900,000	4,600,000
Cost of Equipment		1,500,000	2,300,000
Equipment purchased recorded as investment in Joint Venture		400,000	2,300,000
Payment to purchase U.S. nanoFab facility				35,000,000
Summarized financial information of MP Mask
Current assets	35,794,000	25,701,000
Noncurrent assets	177,769,000	170,226,000
Current liabilities	28,497,000	15,597,000
Noncurrent liabilities	0	0
Net sales	77,900,000	84,216,000	79,766,000
Gross Profit	4,663,000	1,799,000	2,649,000
Net income	$ 4,735,000	$ 831,000	$ 6,691,000